Journal of Nutrition and Metabolism

Journal of Nutrition and Metabolism / 2013 / Article

Clinical Study | Open Access

Volume 2013 |Article ID 653185 |

Elisângela Colpo, Carlos Dalton de Avila Vilanova, Luiz Gustavo Brenner Reetz, Marta Maria Medeiros Frescura Duarte, Iria Luiza Gomes Farias, Edson Irineu Muller, Aline Lima Hermes Muller, Erico Marlon Moraes Flores, Roger Wagner, João Batista Teixeira da Rocha, "A Single Consumption of High Amounts of the Brazil Nuts Improves Lipid Profile of Healthy Volunteers", Journal of Nutrition and Metabolism, vol. 2013, Article ID 653185, 7 pages, 2013.

A Single Consumption of High Amounts of the Brazil Nuts Improves Lipid Profile of Healthy Volunteers

Academic Editor: Cindy Davis
Received20 Apr 2013
Revised15 May 2013
Accepted15 May 2013
Published11 Jun 2013


Background. This study investigates the effects of Brazil nut ingestion on serum lipid profile in healthy volunteers. Methods. Ten healthy subjects were enrolled in the study. Each subject was tested 4 times in a randomized crossover in relation to the ingestion of different serving sizes of the Brazil nut: 0, 5, 20, or 50 g. At each treatment point, peripheral blood was drawn before and at 1, 3, 6, 9, 24, and 48 hours and 5 and 30 days. Blood samples were tested for total cholesterol, high- and low-density lipoprotein cholesterol (HDL-c and LDL-c, resp.), triglycerides, selenium, aspartate and alanine aminotransferases, albumin, total protein, alkaline phosphatase, gamma GT, urea, creatinine, and C-reactive protein. Results. A significant increase of the plasma selenium levels was observed at 6 hours within the groups receiving the nuts. Serum LDL-c was significantly lower, whereas HDL-c was significantly higher 9 hours after the ingestion of 20 or 50 g of nuts. The biochemical parameters of liver and kidney function were not modified by ingestion of nuts. Conclusions. This study shows that the ingestion of a single serving of Brazil nut can acutely improve the serum lipid profile of healthy volunteers.

1. Background

Selenium is an essential nutrient for human health [1], and its biological functions are mediated by the expression of about 20 selenoproteins which have selenocysteine at their active centers [24]. Some selenoproteins, for example, glutathione peroxidase (GPx) and thioredoxin reductase (TrxR), are important antioxidant enzymes [3, 57]. However, high acute selenium ingestion can be toxic to mammals, and epidemiological observations have suggested that dietary overexposure to selenium increases the prevalence of chronic degenerative diseases such as type 2 diabetes, a myotrophic lateral sclerosis, and neoplasias [3, 8, 9].

Selenoproteins can promote cardiovascular benefits possibly via their antioxidant properties. Some isoforms of GPx are known for being able to prevent the oxidative modification of lipids (including those found in lipoproteins), inhibit platelet aggregation, and modulate inflammation by reducing the peroxide tonus [1, 3, 1012]. Additionally, some animals as well as epidemiological studies in humans have identified a putative protective role of some GPx isoforms against cardiovascular damage [1, 13, 14]. However, some large randomized trials investigating the effects of the administration of selenium containing supplements have failed to show a significant protective effect on cardiovascular disease and mortality [1416]. On the other hand, a meta-analysis of 25 observational studies showed a significant inverse association between selenium status with the risk of coronary heart disease (CHD), particularly within populations with low selenium intake or status [14]. A positive association between plasma selenium levels with lower atherogenic index (a reliable indicator of predisposition to heart diseases [17]) has been suggested in nutritional surveys among Japanese [18], Indians [19], and Koreans [20].

Cereals, nuts, meats, and seafood are the major sources of human dietary Se. The Se content in vegetables varies depending on several factors such as the soil in which they are grown, the Se concentration in the irrigating water, and the usage of Se-containing fertilizers [14]. Selenium concentration in Brazil nut varies between 8 and 83 μg/g and is among the highest found within foods consumed by humans [2125]. Brazil nut is also a good source of other nutrients, including unsaturated fatty acids, proteins, fiber, magnesium, phosphorus, thiamin, niacin, vitamin E, vitamin B6, calcium, iron, potassium, zinc, and copper. Moreover, the oily endosperm contains about 50% monounsaturated fatty acids (MUFA) [26].

As pointed out above, Se consumption and selenoenzymes (particularly GPx) have been associated with cardiovascular protection in rodents and humans [12, 14, 27, 28]. Brazil nut has a high content of selenium and could, therefore, have cardioprotective effects. In addition, different types of nuts such as peanuts, almonds, walnuts, and macadamia nuts, among others, have been shown to modulate the lipid profile in both unhealthy as well as healthy subjects [2936]. This beneficial effect has been attributed to the high levels of MUFA and polyunsaturated fatty acids (PUFA) found in nuts [37].

Fatty acids from nuts are important contributors to the beneficial health effects which protect from the development of CHD [38]. Willett et al. [39] reported that high MUFA diets are associated with a reduced cardiovascular disease-associated mortality. Recently, a few studies have indicated a beneficial effect of long-term Brazil nut intake on serum cholesterol among obese and nonobese subjects [36, 37, 40]. However, the acute effects of the ingestion of Brazil nut on the atherogenic index of healthy subjects have not yet been evaluated. In this study, we investigate the effects of moderate to high amount Brazil nut ingestion on lipid profile, hepatic and kidney biochemical parameters in healthy volunteers to determine either beneficial or potentially toxic effect of selenium.

2. Methods

2.1. Study Subjects

Fifteen healthy subjects (8 men and 7 women) were initially recruited at the Universidade Federal de Santa Maria, Brazil. Study candidates (23–34 years old) were evaluated based on their self-reported medical history and laboratory tests. Early in the study, two male and one female subjects were excluded due to high acute alcohol intake. Two female subjects were diagnosed with hypothyroidism and were, therefore, excluded. Body weight was measured to the nearest 0.01 kg using a digital scale, and height was measured to the nearest 0.1 cm using a wall-mounted stadiometer. The body mass index (BMI) (kilograms per square meter) was calculated, and the subjects were classified according to the World Health Organization guidelines [41]. The demographics and baseline test results of the 10 selected participants (6 men and 4 women) are shown in Table 1. This study has been reviewed and approved by the Universidade Federal de Santa Maria’s Internal Review Board (no. 0240.0.243.000-11), and informed consent was obtained from all participants.

CharacteristicMen ( )Women ( )Reference

Weight (Kg)87 ± 13.859.5 ± 6.6
BMI (Kg/m2)26.9 ± 3.923.4 ± 1.618.5–24.9
Plasma selenium ( g·L−1)42.4 ± 16.636.6 ± 12.353 ± 20.7–161 ± 19
Leucocytes (103/mm3) 7.2 ± 1.47.4 ± 1.73.6–11
Hematocrit (%)44.4 ± 1.638.8 ± 2.8§: 39–53
∣: 36–48
Hemoglobin (g/dL)14.8 ± 0.612.8 ± 1§: 12.8–17.8
∣: 11.6–15.6
Fasting glucose (mg/dL)82.4 ± 7.882.9 ± 7.470–99
Albumin (g/dL)4.7 ± 0.44.8 ± 0.43.5–5.5
Total protein (g/dL)6.5 ± 0.66.9 ± 0.36–8
Cholesterol total (mg/dL)145 ± 4.8143 ± 6.7<200
HDL-c (mg/dL)47.6 ± 2.347.8 ± 2.5≥35
LDL-c (mg/dL)87.7 ± 9.884.5 ± 6.5<130
Triglycerides (mg/dL)60.5 ± 16.953.3 ± 16<150

Results are expressed as mean ± S.D. §: masculine; ∣: females.
2.2. Experimental Design

Each subject was tested 4 times following a randomized crossover regarding the administration of the different amounts of Brazil nut: 0, 5, 20, and 50 g. Two Latin squares of 4 × 4 for the 4 treatments were used to randomize participants into 4 orders of treatment. Prior to each treatment, the volunteers underwent a 30-day washout period.

2.3. Brazil Nut Diet

The volunteers were given instructions by a nutritionist to exclude Se-rich foods from their diets (eggs, egg yolks, garlic, Brazil nut, whole wheat cereal, viscera, etc.) throughout the blood sampling period.

The volunteers were given a balanced diet with daily energy requirement of 25 kcal/kg/day, a diet normocaloric. We applied 24-hour dietary recall (24 hDR) and food frequency questionnaires (FFQ) after the last blood sampling to verify the types of foods consumed during the study period. According to the United States Department of Agriculture—USDA, Brazil nut contains (per 100 g) 14.5 g of protein, 15.1 g of carbohydrates, 63.7 g of total fat (15.3 g SFA, 27.4 g MUFA, and 21 g PUFA), and 7.9 g of dietary fiber, for a total of 2,690 kJ [42].

2.4. Se Determination in Brazil Nut

Samples with mass up to 500 was weighed, transferred to quartz vessels together with 6 mL of concentrated nitric acid. The vessels were heated in a microwave oven with maximum temperature and pressure of 280°C and 80 bar, respectively.

2.5. Lipid Determination in Brazil Nut

The extraction of Brazil nut was performed according to the method described by Bligh and Dyer [43], grinding a known amount of Brazil nuts in the presence of a methanol/chloroform (1 : 2 v/v) mixture at 30 mL/g of fresh weight. The fatty acid methyl esters were analyzed by a gas chromatograph using a procedure described by Christie [44]. The results were expressed as relative percent of total fatty acids according to Visentainer [45].

2.6. Blood Samples Collection

Blood samples were collected by venous puncture prior to and at 1, 3, 6, 9, 24, and 48 hours and 5 and 30 days after the ingestion of nuts. Except for the 6- and 9-hour time points, all volunteers were at a 12-hour fasting period for the collection of blood. Blood samples were collected by venous puncture into Vacutainer (BD Diagnostics, Plymouth, UK) tubes with no anticoagulant and EDTA anticoagulant. Blood samples stored in ice were routinely centrifuged within 1 h after collection at 2500 ×g for 15 min. Aliquots of serum samples were immediately used to assess fasting glucose, total cholesterol (TC), high-density lipoprotein cholesterol (HDL-c), triglycerides, aspartate and alanine aminotransferases (AST and ALT, resp.), albumin, total protein, alkaline phosphatase, gamma GT, urea, creatinine, and C-reactive protein (CRP). Aliquots of plasma were used for selenium measurements. Serum and plasma samples were then stored at −80°C for up to 4 weeks before the analyses.

2.7. Blood Tests

Hemoglobin levels and hematocrit were determined in a Cobas Micros system (Hematology Analyzer, Roche Diagnostics). Fasting glucose, TC, HDL-c, triglycerides, AST, ALT, albumin, total protein, alkaline phosphatase, gamma-GT, urea, creatinine, and CRP measurements were performed using Ortho-Clinical Diagnostics reagents on a fully automated analyzer (Vitros 950 dry chemistry system, Johnson & Johnson, Rochester, NY, USA). Low-density lipoprotein cholesterol (LDL-c) was calculated using the Friedewald equation [46].

2.8. Atherogenic Index (AI) Determination

The atherogenic index was calculated as the ratio between total cholesterol and HDL-c or as the ratio between LDL-c and HDL-c concentrations according to Kinosian et al. [47] and Lemieux et al. [48].

2.9. Se Concentration in Plasma

The plasma Se concentration was determined using atomic absorption spectrometry with graphite furnace atomizer (GFAAS) and Zeeman Effect background correction. Samples were diluted with Triton X-100. Palladium chemical modifier, wavelength 196.0 nm, pyrolysis temperature 140°C, and atomization temperature 220°C were used.

2.10. Statistical Analysis

Data are expressed as mean ± Standard Deviation (SD). The statistical analysis was performed using analysis of variance with measure repeated (ANOVA) and nonparametric tests (Wilcoxon). Descriptive statistics was performed for all baseline characteristics. Differences were considered significant when .

3. Results

The volunteers included in the study were 24.7 ± 3.4 years old (range 23–34 years old). Demographic, anthropometric, and laboratory characteristics are listed in Table 1.

The average Se concentration in Brazil nut was 31.25 ± 18.7 μg/g. Therefore, the net Se intake was about 156 μg, 625 μg, and 1560 μg for the groups ingesting 5, 20, and 50 g of nuts, respectively. The estimated fat intake from nuts is shown in Table 2.

Fatty acidsg/100 gSD



 C18:1n9 cis28.611.52


 C18:2n6 cis26.251.07


MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids; SFA: saturated fatty acids.

The biochemical parameters of liver and kidney function in healthy volunteers, such as AST, ALT, alkaline phosphatase, Gama GT, urea, and creatinine, were not modified by ingestion of nuts, indicating an absence of hepatic and renal toxicity of high amounts of Brazil nuts intake. PCR was also evaluated, and there was no change in its levels after ingestion of Brazil nuts (data not shown).

Plasma selenium levels were significantly increased in all groups 6 hours after the ingestion of Brazil nut. Moreover, at the highest dose (50 g) the Se increase was evident starting at as early as 3 h and remained above baseline levels for up to 24 h (Figure 1). At 48 hours, the plasma Se levels did not differ from its baseline concentration (Figure 1).

Serum LDL-c levels were significantly lower starting at 9 hours after the ingestion of nuts within the groups receiving 20 or 50 g and reached a steady level at 48 hours (Figure 2). Subjects that consumed higher amounts of Brazil nut exhibited an increase in HDL-c starting at 6 hours after the intake which reached a stable level at 5 days (Figure 3, ).

Interestingly, the ingestion of 20 g of Brazil nut determined a more pronounced decrease in LDL-c levels as well as a higher increase in HDL-c than did 50 g. These results suggest that eating an average of 4 nuts might be enough to improve the levels of LDL-c and HDL-c for up to 30 days.

Accordingly, the AI (TC/HDL-c and LDL-c/HDL-c ratio) was decreased in subjects that consumed 20 and 50 g of Brazil nut ( , data not shown). Serum triglycerides and total cholesterol did not significantly vary ( ) within the study time frame (data not shown).

Even though the measured plasma Se concentrations did not significantly vary following the ingestion of 5, 20, or 50 g of nuts, changes in LDL-c and HDL-c were only observed with the ingestion of 20 or 50 g which persisted for up to 30 days. These results raise the question of whether the beneficial effects of Brazil nut on the atherogenic index may be due to factors other than selenium (MUFA and PUFA perhaps), highlighting the importance of studying the separate and combined effect of selenium and fatty acids on atherogenic indexes.

4. Discussion

Regular nut intake has been associated with many health benefits in adults [37, 49, 50]. The results of this study support the notion that the consumption of a single serving of nuts can acutely beneficially modify serum lipids.

Contrasting with diets rich in SFA, MUFA- and PUFA-rich foods are potentially beneficial for health [38]. Nuts are generally low in saturated fatty acids and high in unsaturated fatty acids [51]. Unsaturated fatty acids (both mono- and polyunsaturated) have been shown to reduce serum TC and LDL-c. Brazil nut is a good source of unsaturated fat (~50% MUFA). However, despite knowing that the Brazil nut has high concentrations of unsaturated fatty acids when compared with other nuts such as macadamias, almonds, walnuts, pecans, pistachios, and peanuts, the Brazil nut has a relatively higher content of SFAs.

Therefore, the increase in HDL-c observed in this present study may be attributed to the higher MUFA and SFA content in Brazil nut [52]. According to Riccardi et al. [53], SFA and MUFA increase HDL-c, whereas high intakes of PUFA decrease HDL-c. Unsaturated fatty acids have been shown to increase HDL-c less than SFAs do [54]. Furthermore, while the unsaturated fatty acid profile of nuts (high MUFA and PUFA) is thought to mediate the majority of the beneficial effects of nuts on serum lipids, other components such as fiber and selenium might contribute to these effects [14, 26, 31, 55].

Many studies have shown that chronic intake of varying amounts of nuts is effective to increase the blood concentrations of Se and improve lipid profile [2937, 40, 5659]. A meta-analysis by Flores-Mateo et al. [14] based on several observational studies pointed to an inverse correlation between plasma selenium concentrations and coronary heart disease incidence. But the validity of such correlations needs further confirmation. Stranges et al. [60] concluded that an increase in plasma selenium in adult population was associated with increased total and non-HDL cholesterol levels but not with HDL-c. Moreover, evidence showing that low selenium status is a cardiovascular risk factor must still be considered provisional.

In conclusion, the results obtained here suggest that the consumption of a single serving of Brazil nut is sufficient to improve the lipid profile of healthy volunteers (lowered LDL-c and raised HDL-c), without producing hepatic and renal toxicity of high amounts of Brazil nuts intake. However, further investigation is needed to validate the beneficial effects of Brazil nut because here we have used a small number of subjects. In addition, it is also important to evaluate the isolated and combined effects of selenium and/or unsaturated fatty acids found in Brazil nuts on atherogenic parameters in order to better understand their mechanistic role in modulating cardiac indexes in healthy and dyslipidemic subjects. In addition, the evaluation of the effects of chronic consumption of Brazil nuts and the inclusion of dyslipidemic patients are paths to be followed.


GPx:Glutathione peroxidase
TrxR:Thioredoxin  reductase
CHD:Coronary heart disease
MUFA:Monounsaturated fatty acids
PUFA:Polyunsaturated fatty acids
SFA:Saturated fatty acids
BMI:Body mass index
24 hDR:24-hour dietary recall (24 hDR)
FFQ:Food frequency questionnaires
TC:Total cholesterol
HDL-c:High-density lipoprotein cholesterol
LDL-c:Low-density lipoprotein cholesterol
AI:Atherogenic index
AST:Aspartate aminotransferases
ALT:Alanine aminotransferases
CRP:C-reactive protein.

Conflict of Interests

On behalf of all authors, the corresponding author states that there is no conflict of interests.

Authors’ Contribution

João Batista Teixeira da Rocha designed the research, analyzed and interpreted data and wrote the paper; Elisângela Colpo, Carlos Dalton de Avila Vilanova, Luiz Gustavo Brenner Reetz, Marta Maria Medeiros Frescura Duarte, Iria Luiza Gomes Farias, Edson Irineu Muller, Aline Lima Hermes Muller, Erico Marlon Moraes Flores, and Roger Wagner conducted the research, compiled and interpreted the data, and edited the paper. All authors read and approved the final paper.


This work was financed by grants received from the National Counsel of Technological and Scientific Development (CNPq).


  1. M. P. Rayman, H. G. Infante, and M. Sargent, “Food-chain selenium and human health: spotlight on speciation,” British Journal of Nutrition, vol. 100, no. 2, pp. 238–253, 2008. View at: Publisher Site | Google Scholar
  2. G. V. Kryukov, S. Castellano, S. V. Novoselov et al., “Characterization of mammalian selenoproteomes,” Science, vol. 300, no. 5624, pp. 1439–1443, 2003. View at: Publisher Site | Google Scholar
  3. C. W. Nogueira and J. B. T. Rocha, “Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds,” Archives of Toxicology, vol. 85, no. 11, pp. 1313–1359, 2011. View at: Publisher Site | Google Scholar
  4. B. A. Carlson, M.-H. Yoo, P. A. Tsuji, V. N. Gladyshev, and D. L. Hatfield, “Mouse models targeting selenocysteine tRNA expression for elucidating the role of selenoproteins in health and development,” Molecules, vol. 14, no. 9, pp. 3509–3527, 2009. View at: Publisher Site | Google Scholar
  5. R. F. Burk and K. E. Hill, “Regulation of selenoproteins,” Annual Review of Nutrition, vol. 13, pp. 65–81, 1993. View at: Google Scholar
  6. R. F. Burk, K. E. Hill, and A. K. Motley, “Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P,” Journal of Nutrition, vol. 133, no. 5, pp. 1517S–1520S, 2003. View at: Google Scholar
  7. M. P. Rayman, “Selenium and human health,” The Lancet, vol. 379, no. 9822, pp. 1256–1268, 2012. View at: Publisher Site | Google Scholar
  8. M. Vinceti, T. Maraldi, M. Bergomi, and C. Malagoli, “Risk of chronic low-dose selenium overexposure in humans: insights from epidemiology and biochemistry,” Reviews on Environmental Health, vol. 24, no. 3, pp. 231–248, 2009. View at: Google Scholar
  9. M. Vinceti, F. Bonvicini, K. J. Rothman, L. Vescovi, and F. Wang, “The relation between amyotrophic lateral sclerosis and inorganic selenium in drinking water: a population-based case-control study,” Environmental Health, vol. 9, no. 1, pp. 77–84, 2010. View at: Publisher Site | Google Scholar
  10. H. Tapiero, D. M. Townsend, and K. D. Tew, “The antioxidant role of selenium and seleno-compounds,” Biomedicine and Pharmacotherapy, vol. 57, no. 3, pp. 134–144, 2003. View at: Publisher Site | Google Scholar
  11. A. F. D. Bem, M. Farina, R. D. L. Portella et al., “Diphenyl diselenide, a simple glutathione peroxidase mimetic, inhibits human LDL oxidation in vitro,” Atherosclerosis, vol. 201, no. 1, pp. 92–100, 2008. View at: Publisher Site | Google Scholar
  12. S. Blankenberg, H. J. Rupprecht, C. Bickel et al., “Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease,” The New England Journal of Medicine, vol. 349, no. 17, pp. 1605–1613, 2003. View at: Publisher Site | Google Scholar
  13. M. Torzewski, V. Ochsenhirt, A. L. Kleschyov et al., “Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 4, pp. 850–857, 2007. View at: Publisher Site | Google Scholar
  14. G. Flores-Mateo, A. Navas-Acien, R. Pastor-Barriuso, and E. Guallar, “Selenium and coronary heart disease: a meta-analysis,” American Journal of Clinical Nutrition, vol. 84, no. 4, pp. 762–773, 2006. View at: Google Scholar
  15. S. Stranges, J. R. Marshall, M. Trevisan et al., “Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial,” American Journal of Epidemiology, vol. 163, no. 8, pp. 694–699, 2006. View at: Publisher Site | Google Scholar
  16. S. M. Lippman, E. A. Klein, P. J. Goodman et al., “Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT),” The Journal of the American Medical Association, vol. 301, no. 1, pp. 39–51, 2009. View at: Publisher Site | Google Scholar
  17. J.-P. Després, I. Lemieux, G.-R. Dagenais, B. Cantin, and B. Lamarche, “HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study,” Atherosclerosis, vol. 153, no. 2, pp. 263–272, 2000. View at: Publisher Site | Google Scholar
  18. Y. Miyazaki, H. Koyama, M. Nojiri, and S. Suzuki, “Relationship of dietary intake of fish and non-fish selenium to serum lipids in Japanese rural coastal community,” Journal of Trace Elements in Medicine and Biology, vol. 16, no. 2, pp. 83–90, 2002. View at: Google Scholar
  19. K. Hughes and C.-N. Ong, “Vitamins, selenium, iron, and coronary heart disease risk in Indians, Malays, and Chinese in Singapore,” Journal of Epidemiology and Community Health, vol. 52, no. 3, pp. 181–185, 1998. View at: Google Scholar
  20. O. Lee, J. Moon, and Y. Chung, “The relationship between serum selenium levels and lipid profiles in adult women,” Journal of Nutritional Science and Vitaminology, vol. 49, no. 6, pp. 397–404, 2003. View at: Google Scholar
  21. A. P. Vonderheide, K. Wrobel, S. S. Kannamkumarath et al., “Characterization of selenium species in Brazil nuts by HPLC-ICP-MS and ES-MS,” Journal of Agricultural and Food Chemistry, vol. 50, no. 20, pp. 5722–5728, 2002. View at: Publisher Site | Google Scholar
  22. E. Dumont, L. de Pauw, F. Vanhaecke, and R. Cornelis, “Speciation of Se in Bertholletia excelsa (Brazil nut): a hard nut to crack?” Food Chemistry, vol. 95, no. 4, pp. 684–692, 2006. View at: Publisher Site | Google Scholar
  23. J. C. Chang, W. B. Gutemann, C. M. Reid, and D. J. Lisk, “Selenium content of brazil nuts from two geographic locations in Brazil,” Chemosphere, vol. 30, no. 4, pp. 801–802, 1995. View at: Publisher Site | Google Scholar
  24. S. S. Kannamkumarath, K. Wrobel, K. Wrobel, A. Vonderheide, and J. A. Caruso, “HPLC-ICP-MS determination of selenium distribution and speciation in different types of nut,” Analytical and Bioanalytical Chemistry, vol. 373, no. 6, pp. 454–460, 2002. View at: Publisher Site | Google Scholar
  25. E. Bodó, Z. Stefánka, I. Ipolyi, C. Sörös, M. Dernovics, and P. Fodor, “Preparation, homogeneity and stability studies of a candidate LRM for Se speciation,” Analytical and Bioanalytical Chemistry, vol. 377, no. 1, pp. 32–38, 2003. View at: Publisher Site | Google Scholar
  26. J. Yang, “Brazil nuts and associated health benefits: a review,” LWT—Food Science and Technology, vol. 42, no. 10, pp. 1573–1580, 2009. View at: Publisher Site | Google Scholar
  27. M. A. Forgione, A. Cap, R. Liao et al., “Heterozygous cellular glutathione peroxidase deficiency in the mouse: abnormalities in vascular and cardiac function and structure,” Circulation, vol. 106, no. 9, pp. 1154–1158, 2002. View at: Publisher Site | Google Scholar
  28. J. H. Kelly Jr. and J. Sabaté, “Nuts and coronary heart disease: an epidemiological perspective,” The British Journal of Nutrition, vol. 96, pp. S61–S67, 2006. View at: Google Scholar
  29. F. McKiernan, P. Lokko, A. Kuevi et al., “Effects of peanut processing on body weight and fasting plasma lipids,” British Journal of Nutrition, vol. 104, no. 3, pp. 418–426, 2010. View at: Publisher Site | Google Scholar
  30. M. Bes-Rastrollo, N. M. Wedick, M. A. Martinez-Gonzalez, T. Y. Li, L. Sampson, and F. B. Hu, “Prospective study of nut consumption, long-term weight change, and obesity risk in women,” American Journal of Clinical Nutrition, vol. 89, no. 6, pp. 1913–1919, 2009. View at: Publisher Site | Google Scholar
  31. J. Sabaté, G. E. Fraser, K. Burke, S. F. Knutsen, H. Bennett, and K. D. Lindsted, “Effects of walnuts on serum lipid levels and blood pressure in normal men,” The New England Journal of Medicine, vol. 328, no. 9, pp. 603–607, 1993. View at: Publisher Site | Google Scholar
  32. F. B. Hu, M. J. Stampfer, J. E. Manson et al., “Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study,” British Medical Journal, vol. 317, no. 7169, pp. 1341–1345, 1998. View at: Google Scholar
  33. J. Sabaté and G. E. Fraser, “Nuts: a new protective food against coronary heart disease,” Current Opinion in Lipidology, vol. 5, no. 1, pp. 11–16, 1994. View at: Publisher Site | Google Scholar
  34. A. Chisholm, K. Mc Auley, J. Mann, S. Williams, and M. Skeaff, “Cholesterol lowering effects of nuts compared with a Canola oil enriched cereal of similar fat composition,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 15, no. 4, pp. 284–292, 2005. View at: Publisher Site | Google Scholar
  35. J. Sabaté, K. Oda, and E. Ros, “Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials,” Archives of Internal Medicine, vol. 170, no. 9, pp. 821–827, 2010. View at: Publisher Site | Google Scholar
  36. C. Cominetti, M. C. de Bortoli, A. B. Garrido Jr., and S. M. Cozzolino, “Brazilian nut consumption improves selenium status and glutathione peroxidase activity and reduces atherogenic risk in obese women,” Nutrition Research, vol. 32, no. 6, pp. 403–407, 2012. View at: Publisher Site | Google Scholar
  37. C. C. Strunz, T. V. Oliveira, J. C. M. Vinagre, A. Lima, S. Cozzolino, and R. C. Maranhão, “Brazil nut ingestion increased plasma selenium but had minimal effects on lipids, apolipoproteins, and high-density lipoprotein function in human subjects,” Nutrition Research, vol. 28, no. 3, pp. 151–155, 2008. View at: Publisher Site | Google Scholar
  38. E. Ros and J. Mataix, “Fatty acid composition of nuts—implications for cardiovascular health,” The British Journal of Nutrition, vol. 96, pp. S29–S35, 2006. View at: Google Scholar
  39. W. C. Willett, F. Sacks, A. Trichopoulou et al., “Mediterranean diet pyramid: a cultural model for healthy eating,” American Journal of Clinical Nutrition, vol. 61, no. 6, pp. 1402S–1406S, 1995. View at: Google Scholar
  40. P. A. Maranhão, L. G. Kraemer-Aguiar, C. L. de Oliveira et al., “Brazil nuts intake improves lipid profile, oxidative stress and microvascular function in obese adolescents: a randomized controlled trial,” Nutrition and Metabolism, vol. 8, pp. 32–40, 2011. View at: Publisher Site | Google Scholar
  41. WHO, Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation, WHO Technical Report Series, no. 894, WHO, Geneva, Switzerland, 2000.
  42. USDA National nutrient database for standard reference, 2006,
  43. E. G. Bligh and W. J. Dyer, “A rapid method of total lipid extraction and purification,” Canadian Journal of Biochemistry and Physiology, vol. 37, no. 8, pp. 911–917, 1959. View at: Google Scholar
  44. W. W. Christie, “A simple procedure for rapid transmethylation of glycerolipids and cholesteryl esters,” Journal of Lipid Research, vol. 23, no. 7, pp. 1072–1075, 1982. View at: Google Scholar
  45. J. V. Visentainer, “Aspectos analíticos da resposta do detector de ionização em chama para ésteres de ácidos graxos em biodiesel e alimentos,” Química Nova, vol. 35, no. 2, pp. 274–279, 2012. View at: Publisher Site | Google Scholar
  46. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at: Google Scholar
  47. B. Kinosian, H. Glick, and G. Garland, “Cholesterol and coronary heart disease: predicting risk by levels and ratios,” Annals of Internal Medicine, vol. 121, no. 9, pp. 641–647, 1994. View at: Google Scholar
  48. I. Lemieux, B. Lamarche, C. Couillard et al., “Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men,” Archives of Internal Medicine, vol. 161, no. 22, pp. 2685–2692, 2001. View at: Google Scholar
  49. C. Ip and D. J. Lisk, “Bioactivity of selenium from Brazil nut for cancer prevention and selenoenzyme maintenance,” Nutrition and Cancer, vol. 21, no. 3, pp. 203–212, 1994. View at: Google Scholar
  50. C. D. Thomson, A. Chisholm, S. K. McLachlan, and J. M. Campbell, “Brazil nuts: an effective way to improve selenium status,” American Journal of Clinical Nutrition, vol. 87, no. 2, pp. 379–384, 2008. View at: Google Scholar
  51. US Department of Agriculture, Agricultural Research Service, Nutrient Database for Standard Reference—Release 15, 2001.
  52. J. Mukuddem-Petersen, W. Oosihuizen, and J. C. Jerling, “A systematic review of the effects of nuts on lipid profiles in humans,” Journal of Nutrition, vol. 135, no. 9, pp. 2082–2089, 2005. View at: Google Scholar
  53. G. Riccardi, A. A. Rivellese, and C. M. Williams, “The cardiovascular system,” in Nutrition and Metabolism, M. J. Gibney, I. A. Macdonald, and H. M. Roche, Eds., pp. 224–246, Blackwell Science, Oxford, UK, 2003. View at: Google Scholar
  54. R. P. Mensink, P. L. Zock, A. D. M. Kester, and M. B. Katan, “Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials,” American Journal of Clinical Nutrition, vol. 77, no. 5, pp. 1146–1155, 2003. View at: Google Scholar
  55. A. E. Griel and P. M. Kris-Etherton, “Tree nuts and the lipid profile: a review of clinical studies,” The British Journal of Nutrition, vol. 96, pp. S68–S78, 2006. View at: Google Scholar
  56. C. E. O'Neil, D. R. Keast, V. L. Fulgoni, and T. A. Nicklas, “Tree nut consumption improves nutrient intake and diet quality in US adults: an analysis of National Health and Nutrition Examination Survey (NHANES) 1999–2004,” Asia Pacific Journal of Clinical Nutrition, vol. 19, no. 1, pp. 142–150, 2010. View at: Google Scholar
  57. M. B. Stockler-Pinto, J. Lobo, C. Moraes et al., “Effect of Brazil nut supplementation on plasma levels of selenium in hemodialysis patients: 12 months of follow-up,” Journal of Renal Nutrition, vol. 22, pp. 434–439, 2012. View at: Publisher Site | Google Scholar
  58. C. M. Alper and R. D. Mattes, “Peanut consumption improves indices of cardiovascular disease risk in healthy adults,” Journal of the American College of Nutrition, vol. 22, no. 2, pp. 133–141, 2003. View at: Google Scholar
  59. M. J. Sheridan, J. N. Cooper, M. Erario, and C. E. Cheifetz, “Pistachio nut consumption and serum lipid levels,” Journal of the American College of Nutrition, vol. 26, no. 2, pp. 141–148, 2007. View at: Google Scholar
  60. S. Stranges, M. Laclaustra, C. Ji et al., “Higher selenium status is associated with adverse blood lipid profile in British adults,” Journal of Nutrition, vol. 140, no. 1, pp. 81–87, 2010. View at: Publisher Site | Google Scholar

Copyright © 2013 Elisângela Colpo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.